In the risk classification recommended by the European Association of Urology (EAU) and other societies in the guideline, patients with prostate cancer are classified as low–intermediate–high-risk group in terms of both local recurrence and active surveillance according to PSA, ISUP grade, and clinical stage [4,21]. Here, KLK3 is linked to prostate carcinoma.